Rankings
▼
Calendar
LXRX (Lexicon Pharmaceuticals, Inc.) Stock Financials & Earnings | Market Cap Arena
LXRX
Lexicon Pharmaceuticals, Inc.
Mkt Cap
$704M
Healthcare
·
Biotechnology
·
🇺🇸 United States
·
NASDAQ
Revenue (TTM)
$71M
Net Income (TTM)
-$69M
EPS (TTM)
-$0.19
Free Cash Flow (TTM)
-$44M
Gross Margin
63.1%
Op. Margin
-94.4%
Net Margin
-96.8%
FCF Margin
-62.1%
P/S Ratio (TTM)
9.9x
P/E Ratio (TTM)
—
YoY Rev Growth
+1255.2%
Employees
—
Earnings Reports
▶
Q3 2025
Browse All Reports
Quarterly
FY
Revenue & Profitability
Revenue
Gross Profit
Operating Income
Quarter
Revenue
Gross Profit
Op. Income
Q4 22
$28K
-$75K
-$30M
Q1 23
$24K
$24K
-$31M
Q2 23
$317K
$309K
-$44M
Q3 23
$162K
$155K
-$50M
Q4 23
$702K
-$14M
-$47M
Q1 24
$1M
$955K
-$45M
Q2 24
$2M
$1M
-$55M
Q3 24
$2M
$2M
-$64M
Q4 24
$27M
$621K
-$33M
Q1 25
$1M
$1M
-$26M
Q2 25
$29M
$29M
$4M
Q3 25
$14M
$14M
-$12M
marketcaparena.com
Valuation
P/S Ratio
P/E Ratio
Quarter
P/S
P/E
Q4 22
5062.2x
—
Q1 23
5584.5x
—
Q2 23
1724.6x
—
Q3 23
1325.1x
—
Q4 23
583.9x
—
Q1 24
304.5x
—
Q2 24
193.3x
—
Q3 24
134.6x
—
Q4 24
22.6x
—
Q1 25
22.5x
—
Q2 25
12.0x
—
Q3 25
9.9x
—
marketcaparena.com
Operating Cash Flow
Operating Cash Flow
Free Cash Flow
Quarter
Operating CF
Free CF
Q1 23
-$32M
-$32M
Q2 23
-$38M
-$38M
Q3 23
-$42M
-$42M
Q4 23
-$51M
-$51M
Q1 24
-$55M
-$55M
Q2 24
-$49M
-$49M
Q3 24
-$54M
-$54M
Q4 24
-$21M
-$22M
Q1 25
-$44M
-$44M
Q2 25
$17M
$17M
Q3 25
$0
$0
Q4 25
-$17M
-$17M
marketcaparena.com
Capital Expenditures
CapEx
Quarter
CapEx
Q1 23
$248K
Q2 23
$139K
Q3 23
$83K
Q4 23
$0
Q1 24
$0
Q2 24
$250K
Q3 24
$307K
Q4 24
$474K
Q1 25
$0
Q2 25
$0
Q3 25
$0
Q4 25
$0
marketcaparena.com
OpEx vs Revenue Growth (YoY)
Revenue Growth
OpEx Growth
Quarter
Revenue Growth
OpEx Growth
Q4 22
+100.0%
+19.6%
Q1 23
-35.1%
+33.1%
Q2 23
+805.7%
+85.3%
Q3 23
+315.4%
+115.2%
Q4 23
+2407.1%
+56.5%
Q1 24
+4608.3%
+49.1%
Q2 24
+419.6%
+27.9%
Q3 24
+980.2%
+31.4%
Q4 24
+3682.6%
+25.0%
Q1 25
+11.7%
-42.0%
Q2 25
+1652.6%
-55.9%
Q3 25
+710.4%
-59.7%
marketcaparena.com
Stock-Based Compensation
SBC ($)
% of Revenue
Quarter
SBC ($)
% of Revenue
Q1 23
$3M
14229.2%
Q2 23
$4M
1203.5%
Q3 23
$4M
2406.2%
Q4 23
$3M
457.5%
Q1 24
$4M
380.7%
Q2 24
$5M
295.0%
Q3 24
$3M
160.1%
Q4 24
$2M
5.8%
Q1 25
$3M
241.1%
Q2 25
$3M
11.1%
Q3 25
$0
0.0%
Q4 25
$3M
—
marketcaparena.com
OpEx Breakdown
R&D
G&A
S&M
SG&A
Quarter
R&D
G&A
S&M
SG&A
Q4 22
$14M
—
—
$16M
Q1 23
$12M
$19M
—
—
Q2 23
$15M
$30M
—
—
Q3 23
$18M
$3M
$30M
—
Q4 23
$15M
—
—
—
Q1 24
$14M
$32M
—
—
Q2 24
$18M
—
—
$39M
Q3 24
$26M
—
—
$40M
Q4 24
$27M
—
—
—
Q1 25
$15M
—
—
$12M
Q2 25
$16M
—
—
$9M
Q3 25
$19M
—
—
$8M
marketcaparena.com
Revenue Segments
License
Product
Quarter
License
Product
Q2 25
$28M
$1M
Q3 25
$13M
$1M
marketcaparena.com
War Chest
Cash & Equivalents
Short-Term Investments
Quarter
Cash
Short-term Investments
Total
Q1 23
$26M
$80M
$106M
Q2 23
$102M
$154M
$257M
Q3 23
$21M
$197M
$218M
Q4 23
$22M
$148M
$170M
Q1 24
$96M
$259M
$356M
Q2 24
$36M
$274M
$310M
Q3 24
$35M
$224M
$258M
Q4 24
$67M
$171M
$238M
Q1 25
$63M
$132M
$195M
Q2 25
$21M
$118M
$139M
Q3 25
$50M
$66M
$116M
Q4 25
$34M
$62M
$96M
marketcaparena.com
Shares Outstanding
Shares Outstanding
Quarter
Shares (Diluted)
QoQ Change
Q4 22
189M
+7.9%
Q1 23
189M
+0.2%
Q2 23
205M
+8.3%
Q3 23
245M
+19.6%
Q4 23
245M
+0.0%
Q1 24
245M
+0.2%
Q2 24
311M
+26.7%
Q3 24
361M
+16.3%
Q4 24
361M
+0.0%
Q1 25
362M
+0.2%
Q2 25
364M
+0.4%
Q3 25
363M
-0.0%
marketcaparena.com
Revenue Per Employee
Revenue / Employee
Year
Revenue/Employee
Employees
FY 14
$183K
125
FY 15
$1M
120
FY 16
$496K
168
FY 17
$519K
174
FY 18
$313K
202
FY 19
$2M
184
FY 20
$308K
78
FY 21
$3K
87
FY 22
$1K
135
FY 23
$4K
285
FY 24
$302K
103
FY 25
$249
200K
marketcaparena.com